AssayMetrics has teamed up with Cambridge Research Biochemicals to develop Fluorescence Lifetime technology.
Fluorescence Lifetime is a new assay technology used in the biochemical screening of new drugs in High Throughput Screening and compound characterisation roles in the pharmaceutical industry.
The collaboration involves Cambridge Research Biochemicals making key peptide substrates labelled with AssayMetrics’ Fluorescence Lifetime dyes.
The peptides are used to screen novel drugs in equipment such as AssayMetrics’ Fluospec FL reader and are employed in assays involving kinases, proteases, protein:protein interactions and other target enzyme systems.
